Monika B Dolinska Selected Research

Oculocutaneous albinism type 1

7/2021	Characterization of Temperature-Dependent Kinetics of Oculocutaneous Albinism-Causing Mutants of Tyrosinase.
1/2018	Dynamic analysis of human tyrosinase intra-melanosomal domain and mutant variants to further understand oculocutaneous albinism type 1.
12/2017	The consequences of deglycosylation of recombinant intra-melanosomal domain of human tyrosinase.
1/2017	Purification of Recombinant Human Tyrosinase from Insect Larvae Infected with the Baculovirus Vector.
1/2017	Oculocutaneous albinism type 1: link between mutations, tyrosinase conformational stability, and enzymatic activity.
10/2011	Nitisinone improves eye and skin pigmentation defects in a mouse model of oculocutaneous albinism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Monika B Dolinska Research Topics

Disease

7	Oculocutaneous Albinism (Albinism, Yellow Mutant) 01/2022 - 10/2011
6	Oculocutaneous albinism type 1 07/2021 - 10/2011
2	Albinism 01/2017 - 01/2014
1	Eye Diseases (Eye Disease) 01/2017
1	Uveitis 06/2014
1	Infections 06/2014
1	Neoplasm Metastasis (Metastasis) 06/2014
1	Neoplasms (Cancer) 06/2014
1	Autoimmune Diseases (Autoimmune Disease) 06/2014
1	Blindness (Hysterical Blindness) 01/2014

Drug/Important Bio-Agent (IBA)

8	Monophenol Monooxygenase (Tyrosinase)IBA 07/2021 - 10/2011
6	Melanins (Melanin)IBA 07/2021 - 10/2011
1	Cysteine (L-Cysteine)FDA Link 01/2022
1	dopachromeIBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	AsparagineIBA 12/2017
1	Interleukin-10 (Interleukin 10)IBA 06/2014
1	nitisinone (Orfadin)FDA Link 10/2011

Therapy/Procedure

1	Aftercare (After-Treatment) 06/2014